Haitong Securities

Evergrande Property Services Group, the property management arm of one China’s most debt-laden developers, wrapped up its IPO toward the bottom of price guidance after relying largely on Chinese investors.

Chinese property developer Datang Group Holdings has set its IPO in motion, opening the book for an offer that could fetch up to HK$1.5bn ($197.9m).

JD Health International launched 2020’s largest healthcare listing this week, hitting the road to raise up to HK$27bn ($3.5bn) in a Hong Kong IPO. The issuer blends healthcare and technology, two of the hottest sectors in the IPO market this year. It covered the deal multiple times on the first day. Jonathan Breen reports.

China Resources Mixc Lifestyle Services, the property management business of state-owned developer China Resources Land, kicked off bookbuilding for its Hong Kong listing this week, followed quickly by mainland-based developer Leading Holding Group.

Evergrande Property Services Group, the property management arm of embattled developer Evergrande Group, was wrapping up its Hong Kong IPO on a strong note as GlobalCapital Asia went press, with proceeds of up to HK$15.8bn ($2bn) looking within reach.

JD Health International has hit the road with an up-to HK$27bn ($3.5bn) Hong Kong IPO, set to be the largest primary listing in the city this year.

China's Evergrande Property Services Group has kicked off its IPO, aiming to raise up to HK$15.8bn ($2bn) with strong support from friends-and-family investors.

Central China Real Estate paid up for its $300m return to the bond market on Tuesday, navigating weaker investor sentiment to get its deal over the finish line.

High yield property company Jingrui Holdings raised $240m on Monday as part of an exchange and new money exercise.

JD Health International, Evergrande Property Services Group, detergent maker Blue Moon Group Holdings and video marketing company Netjoy Holdings have started pre-marketing their Hong Kong IPOs.

Gland Pharma has completed India’s largest pharmaceutical IPO, a Rp65bn ($870.6m) deal that sailed through on demand from institutional accounts. But the issuer’s Chinese ties and a wobble in pharma stocks blunted retail investor interest. Jonathan Breen reports.

A flurry of Chinese corporations rushed to the dollar bond market on Wednesday, raising a total of $1.19bn between them.